Cooper Debt to Equity Ratio 2006-2018 | COO

Current and historical debt to equity ratio values for Cooper (COO) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Cooper debt/equity for the three months ending July 31, 2018 was 0.70.
Cooper Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-07-31 $2.25B $3.23B 0.70
2018-04-30 $2.44B $3.19B 0.77
2018-01-31 $2.37B $3.16B 0.75
2017-10-31 $1.15B $3.18B 0.36
2017-07-31 $1.18B $3.09B 0.38
2017-04-30 $1.35B $2.94B 0.46
2017-01-31 $1.20B $2.82B 0.43
2016-10-31 $1.11B $2.70B 0.41
2016-07-31 $1.41B $2.74B 0.52
2016-04-30 $1.41B $2.75B 0.51
2016-01-31 $1.33B $2.61B 0.51
2015-10-31 $1.11B $2.67B 0.41
2015-07-31 $1.07B $2.69B 0.40
2015-04-30 $1.11B $2.62B 0.42
2015-01-31 $1.30B $2.52B 0.52
2014-10-31 $1.28B $2.59B 0.50
2014-07-31 $0.30B $2.68B 0.11
2014-04-30 $0.30B $2.56B 0.12
2014-01-31 $0.30B $2.45B 0.12
2013-10-31 $0.30B $2.42B 0.12
2013-07-31 $0.22B $2.44B 0.09
2013-04-30 $0.29B $2.34B 0.13
2013-01-31 $0.38B $2.25B 0.17
2012-10-31 $0.35B $2.21B 0.16
2012-07-31 $0.45B $2.10B 0.22
2012-04-30 $0.28B $2.04B 0.14
2012-01-31 $0.37B $1.94B 0.19
2011-10-31 $0.33B $1.94B 0.17
2011-07-31 $0.41B $1.89B 0.22
2011-04-30 $0.52B $1.81B 0.29
2011-01-31 $0.59B $1.72B 0.34
2010-10-31 $0.59B $1.67B 0.36
2010-07-31 $0.62B $1.59B 0.39
2010-04-30 $0.70B $1.54B 0.45
2010-01-31 $0.72B $1.55B 0.47
2009-10-31 $0.77B $1.54B 0.50
2009-07-31 $0.80B $1.51B 0.53
2009-04-30 $0.85B $1.43B 0.59
2009-01-31 $0.87B $1.38B 0.63
2008-10-31 $0.86B $1.42B 0.61
2008-07-31 $0.89B $1.50B 0.60
2008-04-30 $0.90B $1.43B 0.63
2008-01-31 $0.88B $1.41B 0.62
2007-10-31 $0.83B $1.46B 0.57
2007-07-31 $0.81B $1.44B 0.56
2007-04-30 $0.82B $1.42B 0.58
2007-01-31 $0.82B $1.40B 0.58
2006-10-31 $0.68B $1.38B 0.49
2006-07-31 $0.70B $1.36B 0.52
2006-04-30 $0.70B $1.33B 0.53
2006-01-31 $0.73B $1.30B 0.56
2005-10-31 $0.63B $1.27B 0.50
2005-07-31 $0.68B $1.26B 0.54
2005-04-30 $0.69B $1.24B 0.56
2005-01-31 $0.72B $1.21B 0.60
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $13.023B $2.139B
The Cooper Companies, Inc. is a global medical device company. Cooper is dedicated to being A Quality of Life Company with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women's health, fertility and diagnostics.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $65.839B 22.43
McKesson (MCK) United States $24.205B 9.25
AmerisourceBergen (ABC) United States $19.202B 13.70
Align Technology (ALGN) United States $18.029B 46.00
Laboratory Of America Holdings (LH) United States $16.578B 15.01
Cardinal Health (CAH) United States $16.524B 11.09
Henry Schein (HSIC) United States $13.120B 21.57
DENTSPLY SIRONA (XRAY) United States $8.279B 16.53
West Pharmaceutical Services (WST) United States $8.159B 40.49
Merit Medical Systems (MMSI) United States $3.360B 39.79
Patterson (PDCO) United States $2.427B 17.06
CONMED (CNMD) United States $1.929B 32.05
STAAR Surgical (STAA) United States $1.784B 183.77
Atrion (ATRI) United States $1.343B 38.40
Antares Pharma (ATRS) United States $0.532B 0.00
Invacare (IVC) United States $0.189B 0.00
Lifevantage (LFVN) United States $0.161B 22.84
Endologix (ELGX) United States $0.106B 0.00
Pro-Dex (PDEX) United States $0.061B 27.17
Aceto (ACET) United States $0.055B 0.00
Biolase (BIOL) United States $0.027B 0.00